tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market
BRNS
Barinthus Biotherapeutics
RESEARCH TOOLSreports
Want to see BRNS full AI Analyst Report?

Barinthus Biotherapeutics (BRNS) Stock Forecast & Price Target

113 Followers
See the Price Targets and Ratings of:

BRNS Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Barinthus
Biotherapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BRNS Stock 12 Month Forecast

There Are No Analyst Ratings for BRNS In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

BRNS Financial Forecast

BRNS Earnings Forecast

Next quarter’s earnings estimate for BRNS is -$0.28 with a range of -$0.28 to -$0.28. The previous quarter’s EPS was -$0.14. BRNS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BRNS has Performed in-line its overall industry.
Next quarter’s earnings estimate for BRNS is -$0.28 with a range of -$0.28 to -$0.28. The previous quarter’s EPS was -$0.14. BRNS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BRNS has Performed in-line its overall industry.

BRNS Sales Forecast

The previous quarter’s earnings for BRNS were $0.00.
The previous quarter’s earnings for BRNS were $0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Alliance Global Partners Analyst forecast on BRNS
James Molloy
Alliance Global Partners
Alliance Global Partners
$7
Buy
821.05%
Upside
Reiterated
03/13/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright Analyst forecast on BRNS
Yi Chen
H.C. Wainwright
H.C. Wainwright
$4
Buy
426.32%
Upside
Reiterated
12/11/25
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
William Blair Analyst forecast on BRNS
Andy Hsieh
William Blair
William Blair
―
Buy
―
Reiterated
08/07/25
William Blair Sticks to Its Buy Rating for Barinthus Biotherapeutics (BRNS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Alliance Global Partners Analyst forecast on BRNS
James Molloy
Alliance Global Partners
Alliance Global Partners
$7
Buy
821.05%
Upside
Reiterated
03/13/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright Analyst forecast on BRNS
Yi Chen
H.C. Wainwright
H.C. Wainwright
$4
Buy
426.32%
Upside
Reiterated
12/11/25
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
William Blair Analyst forecast on BRNS
Andy Hsieh
William Blair
William Blair
―
Buy
―
Reiterated
08/07/25
William Blair Sticks to Its Buy Rating for Barinthus Biotherapeutics (BRNS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Barinthus Biotherapeutics

3 Months
Yi ChenH.C. Wainwright
Success Rate
3/18 ratings generated profit
17%
Average Return
-20.04%
Copying Yi Chen's trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -20.04% per trade.
1 Year
Yi ChenH.C. Wainwright
Success Rate
2/18 ratings generated profit
11%
Average Return
-36.56%
Copying Yi Chen's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -36.56% per trade.
2 Years
Yi ChenH.C. Wainwright
Success Rate
0/18 ratings generated profit
0%
Average Return
-52.21%
Copying Yi Chen's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -52.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BRNS Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
1
1
1
1
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
1
0
In the current month, BRNS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BRNS average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

BRNS Stock Forecast FAQ

What is BRNS’s average 12-month price target, according to analysts?
Currently, no data Available
What is BRNS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for BRNS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is BRNS a Buy, Sell or Hold?
      Currently, no data Available
      What is Barinthus Biotherapeutics’s price target?
      Currently, no data Available
      What do analysts say about Barinthus Biotherapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of BRNS?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.